Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05664802 · ClinicalTrials.gov registry record · NA
e-HERO: Ending the HIV Epidemic in Rural Oklahoma
A NA study of Human Immunodeficiency Virus (HIV), sponsored by Northern Arizona University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05664802: Recruiting NA study of Human Immunodeficiency Virus (HIV), sponsored by Northern Arizona University.
NCT05664802 is a NA study of Human Immunodeficiency Virus (HIV) that is actively recruiting participants, run by Northern Arizona University. The registered enrollment target is 200 participants, below the 498-participant average among 18 other Human Immunodeficiency Virus (HIV) trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05664802, a NA study of Human Immunodeficiency Virus (HIV), is actively recruiting participants, sponsored by Northern Arizona University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to increase HIV and syphilis testing and linkage to care, increase condom use, and promote PrEP uptake among sexual minority men (SMM) and American Indian (AI) men in rural Oklahoma, a state that is an Ending the HIV Epidemic (EHE) priority state. The proposed supplement aims to: refine our preliminary intervention strategy in partnership with a Community Advisory Board (CAB) and rural peer mentors, and to assess feasibility, acceptability, and preliminary impact of the e-HERO intervention.
Primary Outcome
HIV testing uptake is assessed through the request of an at-home rapid HIV test through the e-HERO platforms.
Conditions Studied
Interventions
- BEHAVIORAL e-HERO: Ending the HIV Epidemic in Rural Oklahoma
Study Locations (1)
Arizona
- Northern Arizona University - Flagstaff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2024-08-30 |
| Phase | NA |
What NCT05664802 shows while recruiting
NCT05664802 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 498-participant average among 18 other Human Immunodeficiency Virus (HIV) trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Human Immunodeficiency Virus (HIV) appearing as the primary indexed condition, and to 1 intervention - of which e-HERO: Ending the HIV Epidemic in Rural Oklahoma is the first listed.
NCT05664802 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05664802 about?
NCT05664802 is a clinical study titled "e-HERO: Ending the HIV Epidemic in Rural Oklahoma". The goal of this study is to increase HIV and syphilis testing and linkage to care, increase condom use, and promote PrEP uptake among sexual minority men (SMM) and American Indian (AI) men in rural Oklahoma, a state that is an Ending the HIV Epidemic (EHE) priority state. The proposed supplement ai...
What is the current status of trial NCT05664802?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-12-01. Estimated completion is 2024-08-30.
What conditions does trial NCT05664802 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus (HIV).
What interventions are being tested in trial NCT05664802?
The interventions under investigation include: e-HERO: Ending the HIV Epidemic in Rural Oklahoma (BEHAVIORAL).
Who is sponsoring clinical trial NCT05664802?
This trial is sponsored by Northern Arizona University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05664802 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus (HIV)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05664802's enrollment target sits among peer trials
200 6th of 18 higher than 13 of 18 other Human Immunodeficiency Virus (HIV) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Immunodeficiency Virus (HIV) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Persuasive Health Communication Intervention for HIV/HCV
RECRUITING · NA
-
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
Project neuroARTEMIS
RECRUITING · NA
-
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
ACTIVE NOT RECRUITING · NA
-
Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI